Compounding pharmacies will have to stop producing copycats of tirzepatide, the active ingredient in the blockbuster weight ...

For decades, the United States has led the world in pharmaceutical innovation – developing drugs that combat cancer, heart ...

Zepbound contains the same active ingredient, tirzepatide, as Mounjaro, which is also made by Lilly and is FDA-approved to treat Type 2 diabetes. Some doctors also prescribe Mounjaro "off-label" for ...

Legitimate versions of compound drugs are copies of FDA-approved medications made by licensed pharmacies and are not approved or inspected by the FDA. Drug compounding is allowed when drugs are on ...

Eli Lilly is seeking to further cement its stance as a leader in weight loss drugs in an ad campaign calling out “unapproved” medications.

As it gets harder to offer compounded GLP-1s, many telehealth companies are pivoting to hormone replacement therapy.

The offer may show employers how hard drug manufacturers will compete based on price, in at least some situations.

A federal judge has effectively ended the ability of compounding pharmacies to make their own copies of Eli Lilly’s weight loss and diabetes drugs Zepbound and Mounjaro. In a sealed decision ...

Tirzepatide — a drug that acts both as a GLP-1 agonist and a GIP agonist — is the active ingredient in an even more powerful ...

Danish drugmaker Novo Nordisk said Wednesday that it will drop prices 23% for all doses of Wegovy. The new monthly price of ...

The Oklahoma Poison Center is reporting a “surge” of incoming calls about accidental overdosing of popular injectable drugs used for weight loss and diabetes management. Called GLP-1 agonists and used ...

For decades, the United States has led the world in pharmaceutical innovation — developing drugs that combat cancer, heart ...